PAUL D' ANGIO,保罗Ｄ 安吉尔,保羅Ｄ 安吉爾,PAUL D ANGIO,保罗D 安吉尔,保羅D 安吉爾
申请号：
TW092132008
公开号：
TWI359659B
申请日:
2003.11.14
申请国别(地区):
TW
年份:
2012
代理人:
摘要：
Pharmaceutical compositions and single unit dosage forms of thalidomide and pharmaceutically acceptable prodrugs, salts, solvates, hydrates, or clathrates are disclosed. Also disclosed are methods of treating and preventing diseases and conditions such as, but not limited to, leprosy, chronic graft-vs-host disease, rheumatoid arthritis, sarcoidosis, an inflammatory condition, inflammatory bowel disease, and cancer using the novel dosage forms disclosed herein.本發明揭示沙利竇邁(thalidomide)及其醫藥上容許前藥、鹽類、溶劑化物、水合物或晶籠化合物之醫藥組合物及單一單位劑型。亦揭示使用本文揭示之新穎劑型於治療及預防疾病和病症之方法，例如(但不限於)痲瘋病、慢性移植物-對-宿主疾病、類風濕關節炎、類肉瘤病、炎症性病症、炎症性腸病及癌症。
